1.
J Hosp Med
; 17(11): 917-920, 2022 11.
Artículo
en Inglés
| MEDLINE
| ID: mdl-35527539
Asunto(s)
Fibrilación Atrial , Intervención Coronaria Percutánea , Humanos , Fibrilación Atrial/complicaciones , Fibrilación Atrial/tratamiento farmacológico , Anticoagulantes/uso terapéutico , Quimioterapia Combinada , Inhibidores de Agregación Plaquetaria/uso terapéutico , Fibrinolíticos/uso terapéutico
2.
Cureus
; 14(1): e21481, 2022 Jan.
Artículo
en Inglés
| MEDLINE
| ID: mdl-35223261
RESUMEN
Cardiac amyloidosis is a rare disease caused by the accumulation of protein-based fibrils that deposit into the myocardium, causing disease. The accumulation of amyloid in the heart tissue causes the heart to become increasingly stiff, reducing compliance, with the eventual decline of the heart's systolic function over time as the disease progresses. The restrictive physiology of the disease usually prompts investigation; however, if allowed to progress, the systolic function becomes affected in the later stages of the disease. We present a case of late-stage transthyretin-related amyloidosis (ATTR).